Cerdulatinib-impurities | Pharmaffiliates

Cerdulatinib and its Impurities

Cerdulatinib is under investigation in clinical trial NCT04021082 (CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/refractory Peripheral T-cell Lymphoma (PTCL)). Reference standards of Cerdulatinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 1 results for Cerdulatinib Impurities
PA 03 3830000

Cerdulatinib - API

Cerdulatinib


  • Catalogue No.:PA 03 3830000

  • CAS :

    1198300-79-6

  • Molecular Formula : C20H27N7O3S

  • Molecular Weight : 445.54